Trials

Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a setback for a company still facing thousands of other opioid-related lawsuits around the United States.

The jury weighing fraud charges against former Theranos CEO Elizabeth Holmes departed court Wednesday without reaching a verdict after six days of deliberations.

Jurors in the fraud trial of former Theranos CEO Elizabeth Holmes returned to the courtroom Thursday to listen again to audio recordings that captured Holmes' brash promises about vaunted blood-testing technology that propelled her meteoric rise and scandalous downfall.

The jurors responsible for assessing 11 charges of fraud and conspiracy against former Theranos CEO Elizabeth Holmes are scheduled to begin their third day of deliberations on Thursday.

The high-profile trial of former Theranos CEO Elizabeth Holmes boils down to a single question: Did she cover up defects in her startup's blood-testing technology to rip off investors while potentially endangering the lives of unwitting patients?

NatWest Markets PLC pleaded guilty Tuesday to wire and securities fraud, admitting that its traders in London, Singapore and Connecticut engaged in a number of schemes between 2008 and 2018 to manipulate U.S. Treasury markets.

A British court on Tuesday ordered the ruler of Dubai, Sheikh Mohammed bin Rashid Al Maktoum, to pay his ex-wife and their children close to 550 million pounds ($730 million) in one of the most expensive divorce settlements in British history.

The jurors now responsible for assessing 11 charges of fraud and conspiracy against former Theranos CEO Elizabeth Holmes are scheduled to begin their first full day of deliberations on Monday. They have plenty of evidence to review after a three-month trial that captivated Silicon Valley.

Elizabeth Holmes had his final opportunity Friday to distance the Theranos Inc. founder from the criminal-fraud allegations she faces

Prosecutors in Elizabeth Holmes’s criminal fraud trial made their case one more time in closing arguments Thursday as jurors move closer to deciding the fate of the Theranos Inc. founder.

Cross examination of Theranos founder Elizabeth Holmes has wrapped

Elizabeth Holmes’s surprise turn on the witness stand in her criminal-fraud trial has given jurors a close look at the control she held over her blood-testing startup Theranos Inc., and at the alleged torment she endured in her personal life at the same time.

Disgraced former attorney Michael Avenatti is requesting a new trial after he was convicted last year of trying to extort up to $25 million from NIke by threatening to go public with corruption allegations and cause billions of dollars in valuation losses.

An Alabama woman who says she was falsely arrested for shoplifting at a Walmart and then threatened by the company after her case was dismissed has been awarded $2.1 million in damages.

An Alabama woman who says she was falsely arrested for shoplifting at a Walmart and then threatened by the company after her case was dismissed has been awarded $2.1 million in damages.

FOX Business dives into the details of the SEC's lawsuit against Ripple, what circumstances led to it and the key players involved.

For the first time in her criminal-fraud trial, Elizabeth Holmes on Tuesday took aim at the most serious allegations made against her by prosecutors, offering a narrative of herself as a well-intentioned if inexperienced entrepreneur who had some success in her effort to transform health care.

Elizabeth Holmes took the witness stand Friday afternoon to defend herself against criminal-fraud charges tied to the failure of Theranos Inc.

Jurors heard testimony this week from voices that have been scant in Elizabeth Holmes’s criminal-fraud trial so far: patients who took Theranos Inc. tests, as well as Holmes herself.

Over seven weeks in the criminal fraud trial of Elizabeth Holmes, prosecutors have shown that her startup Theranos Inc. took shortcuts when claims about its revolutionary blood-testing technology became scientifically unfeasible and that employees feared retaliation for raising concerns.